Previous close | 42.20 |
Open | N/A |
Bid | 26.10 |
Ask | 35.80 |
Strike | 460.00 |
Expiry date | 2025-06-20 |
Day's range | 42.20 - 42.20 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call